Behzad Baradaran

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 130

Top Venues

Journal of cellular physiology

Advanced pharmaceutical bulletin

Journal of cellular biochemistry

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Ali Sayadmanesh, Mohamad Azadbakht, Kheirollah Yari, Ali Abedelahi, Hajar Shafaei, Dariush Shanehbandi, Behzad Baradaran, Mohsen Basiri
Characterization of CAR T Cells Manufactured Using Genetically Engineered Artificial Antigen Presenting Cells. Cell journal 25 (10) (2023)
Mina Afrashteh Nour, Farid Ghorbaninezhad, Zahra Asadzadeh, Amir Baghbanzadeh, Hamidreza Hassanian, Patrizia Leone, Mahdi Jafarlou, Nazila Alizadeh, Vito Racanelli, Behzad Baradaran
The emerging role of noncoding RNAs in systemic lupus erythematosus: new insights into the master regulators of disease pathogenesis. Therapeutic advances in chronic disease 14 (2023)
Farid Mostafaei, Somayeh Mahdinloo, Hadi Valizadeh, Salar Hemmati, Mahdieh Abdi, Muhammad Sarfraz, Behzad Baradaran, Parvin Zakeri-Milani
An update review of smart nanotherapeutics and liver cancer: opportunities and challenges. Nanomedicine (London, England) (2023)
Zahra Ghahramanipour, Shiva Alipour, Javad Masoumi, Arman Rostamlou, Amirhossein Hatami-Sadr, Javad Ahmadian Heris, Bahar Naseri, Mahdi Jafarlou, Behzad Baradaran
Regulation of Dendritic Cell Functions by Vitamins as Promising Therapeutic Strategy for Immune System Disorders. Advanced biology (2023)
Mohammad Heiat, Ehsan Rezaei, Javad Gharechahi, Masoumeh Abbasi, Javad Behroozi, Mohammad Ali Abyazi, Behzad Baradaran
Knockdown of SIX4 inhibits pancreatic cancer cells via apoptosis induction. Medical oncology (Northwood, London, England) 40 (10) (2023)
Negin Riazi-Tabrizi, Mohammad Khalaj-Kondori, Sahar Safaei, Mohammad Amini, Hamidreza Hassanian, Mohadeseh Maghsoudi, Shima Hasani, Behzad Baradaran
NRF2 Suppression Enhances the Susceptibility of Pancreatic Cancer Cells, Miapaca-2 to Paclitaxel. Molecular biotechnology (2023)
Fereydoon Abedi-Gaballu, Elham Kamal Kazemi, Seyed Ahmad Salehzadeh, Behnaz Mansoori, Farhad Eslami, Ali Emami, Gholamreza Dehghan, Behzad Baradaran, Behzad Mansoori, William Chi Shing Cho
Metabolic Pathways in Breast Cancer Reprograming: An Insight to Non-Coding RNAs. Cells 11 (19) (2022)
Souzan Najafi, Zohreh Rahimi, Behzad Mansoori, Ali Mohammadi, Fatemeh Mohammadnejad, Mohammad Amini, Ahad Mokhtazadeh, Zahra Asadzadeh, William Chi Shing Cho, Behzad Baradaran
CD44 Suppression Improved the Chemosensitivity of HT-29 Colorectal Cancer Cells to 5-Fluorouracil and Inhibited Cell Migration. Advanced pharmaceutical bulletin 13 (3) (2022)
Nadia Bolandi, Mohammad Hassan Khadem Ansari, Yousef Rasmi, Behzad Baradaran
Cooperative Treatment of Gastric Cancer Using B7-H7 siRNA and Docetaxel; How Could They Modify Their Effectiveness? Advanced pharmaceutical bulletin 13 (3) (2022)
Manouchehr Fadaee, Hajar Abbasi, Sepideh Maralbashi, Behzad Baradaran, Dariush Shanehbandi, Masood Faghih Dinevari, Tohid Kazemi
Docosahexaenoic acid may inhibit immune evasion of colorectal cancer cells through targeting immune checkpoint and immunomodulator genes and their controlling microRNAs. BioFactors (Oxford, England) 48 (5) (2022)
Bita Amir Taghavi, Nazila Alizadeh, Hossein Saeedi, Noora Karim Ahangar, Afshin Derakhshani, Khalil Haji-Asgarzadeh, Nicola Silvestris, Behzad Baradaran, Oronzo Brunetti
Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy. Molecules (Basel, Switzerland) 27 (11) (2022)
Mina Khajehdehi, Mohammad Khalaj-Kondori, Behzad Baradaran
Molecular evidences on anti-inflammatory, anticancer, and memory-boosting effects of frankincense. Phytotherapy research : PTR 36 (3) (2022)
Katayoun Dolatkhah, Nazila Alizadeh, Hanieh Mohajjel-Shoja, Mahdi Abdoli Shadbad, Khalil Hajiasgharzadeh, Leili Aghebati-Maleki, Amir Baghbanzadeh, Negar Hosseinkhani, Noora Karim Ahangar, Behzad Baradaran
B7 immune checkpoint family members as putative therapeutics in autoimmune disease: An updated overview. International journal of rheumatic diseases 25 (3) (2022)
Samane Abbasi, Milad Asghari Totmaj, Masoumeh Abbasi, Saba Hajazimian, Pouya Goleij, Javad Behroozi, Behrouz Shademan, Alireza Isazadeh, Behzad Baradaran
Chimeric antigen receptor T (CAR-T) cells: Novel cell therapy for hematological malignancies. Cancer medicine (2022)
Khalil Hajiasgharzadeh, Mahdi Jafarlou, Behzad Mansoori, Narges Dastmalchi, Behzad Baradaran, Alireza Khabbazi
Inflammatory reflex disruption in COVID-19. Clinical & experimental neuroimmunology (2022)
Monireh Khordadmehr, Reyhaneh Matin, Behzad Baradaran, Elham Baghbani, Farinaz Jigari-Asl, Saeed Noorolyai
The Effect of miR-4800 Restoration on Proliferation and Migration of Human Breast Cancer Cells In Vitro . Advanced pharmaceutical bulletin 13 (2) (2022)
Parvaneh Mahinfar, Behnaz Mansoori, Davoud Rostamzadeh, Behzad Baradaran, William Chi Shing Cho, Behzad Mansoori
The Role of microRNAs in Multidrug Resistance of Glioblastoma. Cancers 14 (13) (2022)
Naser Rasouli, Daryoush Shahbazi-Gahrouei, Simin Hematti, Behzad Baradaran, Roya Salehi, Jaleh Varshosaz, Abbas Jafarizad
Assessment of Oxaliplatin-Loaded Iodine Nanoparticles for Chemoradiotherapy of Human Colorectal Cancer (HT-29) Cells. Polymers 14 (19) (2022)
Behzad Mansoori, Mikkel Green Terp, Ali Mohammadi, Christina Bøg Pedersen, Henrik Jørn Ditzel, Behzad Baradaran, Morten Frier Gjerstorff
HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer. Cancers 13 (20) (2021)
Fereydoon Abedi Gaballu, William Chi Shing Cho, Gholamreza Dehghan, Amir Zarebkohan, Behzad Baradaran, Behzad Mansoori, Soheil Abbaspour-Ravasjani, Ali Mohammadi, Nader Sheibani, Ayuob Aghanejad, Jafar Ezzati Nazhad Dolatabadi
Silencing of HMGA2 by siRNA Loaded Methotrexate Functionalized Polyamidoamine Dendrimer for Human Breast Cancer Cell Therapy. Genes 12 (7) (2021)
Elmira Roshani Asl, Yousef Rasmi, Behzad Baradaran
MicroRNA-124-3p suppresses PD-L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling. Journal of cellular physiology 236 (10) (2021)
Misagh Majidi, Sahar Safaee, Mohammad Amini, Amir Baghbanzadeh, Khalil Hajiasgharzadeh, Shahriar Hashemzadeh, Siamak Sandoghchian Shotorbani, Ahad Mokhtarzadeh, Behzad Baradaran
The effects of chemotherapeutic drugs on PD-L1 gene expression in breast cancer cell lines. Medical oncology (Northwood, London, England) 38 (12) (2021)
Zahra Hasanpour Segherlou, Masoud Nouri-Vaskeh, Sama Noroozi Guilandehi, Amir Baghbanzadeh, Ramin Zand, Behzad Baradaran, Mohammad Zarei
GDF-15: Diagnostic, prognostic, and therapeutic significance in glioblastoma multiforme. Journal of cellular physiology 236 (8) (2021)
Afshin Derakhshani, Shahryar Hashemzadeh, Zahra Asadzadeh, Mahdi Abdoli Shadbad, Farnaz Rasibonab, Hossein Safarpour, Vahid Jafarlou, Antonio Giovanni Solimando, Vito Racanelli, Pankaj Kumar Singh, Souzan Najafi, Darya Javadrashid, Oronzo Brunetti, Nicola Silvestris, Behzad Baradaran
Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine. Cancers 13 (10) (2021)
Shima Makaremi, Zahra Asadzadeh, Nima Hemmat, Amir Baghbanzadeh, Alessandro Sgambato, Farid Ghorbaninezhad, Hossein Safarpour, Antonella Argentiero, Oronzo Brunetti, Renato Bernardini, Nicola Silvestris, Behzad Baradaran
Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects. Biomedicines 9 (9) (2021)
Mahsa Gholizadeh, Mohammad Amin Doustvandi, Fateme Mohammadnejad, Mahdi Abdoli Shadbad, Habib Tajalli, Oronzo Brunetti, Antonella Argentiero, Nicola Silvestris, Behzad Baradaran
Photodynamic Therapy with Zinc Phthalocyanine Inhibits the Stemness and Development of Colorectal Cancer: Time to Overcome the Challenging Barriers? Molecules (Basel, Switzerland) 26 (22) (2021)
Sahar Safaee, Masoumeh Fardi, Nima Hemmat, Neda Khosravi, Afshin Derakhshani, Nicola Silvestris, Behzad Baradaran
Silencing ZEB2 Induces Apoptosis and Reduces Viability in Glioblastoma Cell Lines. Molecules (Basel, Switzerland) 26 (4) (2021)
Leila Tebbi, Behzad Mansoori, Sahar Safaei, Shahriar Hashemzadeh, Masoud Shirmohamadi, Khalil Hajiasgharzadeh, Mahdi Abdoli Shadbad, Behzad Baradaran
MiR-146a Restoration Suppresses Triple-Negative Breast Cancer Cell Migration: A Bioinformatic and In Vitro Study. Advanced pharmaceutical bulletin 12 (4) (2021)
Afshin Khorrami, Pouya Goleij, Vahidreza Karamad, Elham Taheri, Behrouz Shadman, Parisa Emami, Gholamreza Jahangirzadeh, Saba Hajazimian, Alireza Isazadeh, Behzad Baradaran, Mansour Heidari
Identification of a compound heterozygous missense mutation in LAMA2 gene from a patient with merosin-deficient congenital muscular dystrophy type 1A. Journal of clinical laboratory analysis 35 (11) (2021)
Khalil Hajiasgharzadeh, Alireza Khabbazi, Ahad Mokhtarzadeh, Amir Baghbanzadeh, Zahra Asadzadeh, Elham Adlravan, Behzad Baradaran
Cholinergic anti-inflammatory pathway and connective tissue diseases. Inflammopharmacology 29 (4) (2021)
Negar Hosseinkhani, Mahdi Abdoli Shadbad, Mohammad Asghari Jafarabadi, Noora Karim Ahangar, Zahra Asadzadeh, Seyede Momeneh Mohammadi, Parisa Lotfinejad, Nazila Alizadeh, Oronzo Brunetti, Rossella Fasano, Nicola Silvestris, Behzad Baradaran
A Systematic Review and Meta-Analysis on the Significance of TIGIT in Solid Cancers: Dual TIGIT/PD-1 Blockade to Overcome Immune-Resistance in Solid Cancers. International journal of molecular sciences 22 (19) (2021)
Nadia Bolandi, Afshin Derakhshani, Nima Hemmat, Amir Baghbanzadeh, Zahra Asadzadeh, Mina Afrashteh Nour, Oronzo Brunetti, Renato Bernardini, Nicola Silvestris, Behzad Baradaran
The Positive and Negative Immunoregulatory Role of B7 Family: Promising Novel Targets in Gastric Cancer Treatment. International journal of molecular sciences 22 (19) (2021)
Behzad Mansoori, Ali Mohammadi, Henrik Jørn Ditzel, Pascal H G Duijf, Vahid Khaze, Morten Frier Gjerstorff, Behzad Baradaran
HMGA2 as a Critical Regulator in Cancer Development. Genes 12 (2) (2021)
Rossella Fasano, Mahdi Abdoli Shadbad, Oronzo Brunetti, Antonella Argentiero, Angela Calabrese, Patrizia Nardulli, Roberto Calbi, Behzad Baradaran, Nicola Silvestris
Immunotherapy for Hepatocellular Carcinoma: New Prospects for the Cancer Therapy. Life (Basel, Switzerland) 11 (12) (2021)
Nima Hemmat, Haniyeh Asadzadeh, Zahra Asadzadeh, Mahdi Abdoli Shadbad, Behzad Baradaran
The Analysis of Herpes Simplex Virus Type 1 (HSV-1)-Encoded MicroRNAs Targets: A Likely Relationship of Alzheimer's Disease and HSV-1 Infection. Cellular and molecular neurobiology (2021)
Tohid Mahmoudi, Mohammad Pourhassan-Moghaddam, Behnaz Shirdel, Behzad Baradaran, Eden Morales-Narváez, Hamed Golmohammadi
On-Site Detection of Carcinoembryonic Antigen in Human Serum. Biosensors 11 (10) (2021)
Afshin Derakhshani, Zahra Asadzadeh, Hossein Safarpour, Patrizia Leone, Mahdi Abdoli Shadbad, A Ali Heydari, Behzad Baradaran, Vito Racanelli
Regulation of CTLA-4 and PD-L1 Expression in Relapsing-Remitting Multiple Sclerosis Patients after Treatment with Fingolimod, IFNβ-1α, Glatiramer Acetate, and Dimethyl Fumarate Drugs. Journal of personalized medicine 11 (8) (2021)
Hassan Karami, Afshin Derakhshani, Mohammad Ghasemigol, Mohammad Fereidouni, Ebrahim Miri-Moghaddam, Behzad Baradaran, Neda Jalili Tabrizi, Souzan Najafi, Antonio Giovanni Solimando, Leigh Matthew Marsh, Nicola Silvestris, Simona De Summa, Angelo Virgilio Paradiso, Vito Racanelli, Hossein Safarpour
Weighted Gene Co-Expression Network Analysis Combined with Machine Learning Validation to Identify Key Modules and Hub Genes Associated with SARS-CoV-2 Infection. Journal of clinical medicine 10 (16) (2021)
Noora Karim Ahangar, Nima Hemmat, Mohammad Khalaj-Kondori, Mahdi Abdoli Shadbad, Hani Sabaie, Ahad Mokhtarzadeh, Nazila Alizadeh, Afshin Derakhshani, Amir Baghbanzadeh, Katayoun Dolatkhah, Nicola Silvestris, Behzad Baradaran
The Regulatory Cross-Talk between microRNAs and Novel Members of the B7 Family in Human Diseases: A Scoping Review. International journal of molecular sciences 22 (5) (2021)
Afshin Derakhshani, Nima Hemmat, Zahra Asadzadeh, Moslem Ghaseminia, Mahdi Abdoli Shadbad, Golamreza Jadideslam, Nicola Silvestris, Vito Racanelli, Behzad Baradaran
Arginase 1 (Arg1) as an Up-Regulated Gene in COVID-19 Patients: A Promising Marker in COVID-19 Immunopathy. Journal of clinical medicine 10 (5) (2021)
Darya Javadrashid, Amir Baghbanzadeh, Afshin Derakhshani, Patrizia Leone, Nicola Silvestris, Vito Racanelli, Antonio Giovanni Solimando, Behzad Baradaran
Pancreatic Cancer Signaling Pathways, Genetic Alterations, and Tumor Microenvironment: The Barriers Affecting the Method of Treatment. Biomedicines 9 (4) (2021)
Behzad Mansoori, Nicola Silvestris, Ali Mohammadi, Vahid Khaze, Elham Baghbani, Ahad Mokhtarzadeh, Dariush Shanehbandi, Afshin Derakhshani, Pascal H G Duijf, Behzad Baradaran
miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on Breast Cancer Cells and Patient Prognosis. Genes 12 (2) (2021)
Mostafa Mostafazadeh, Nasser Samadi, Houman Kahroba, Behzad Baradaran, Sanya Haiaty, Mohammad Nouri
Potential roles and prognostic significance of exosomes in cancer drug resistance. Cell & bioscience 11 (1) (2021)
Nima Hemmat, Zahra Asadzadeh, Noora Karim Ahangar, Hajar Alemohammad, Basira Najafzadeh, Afshin Derakhshani, Amir Baghbanzadeh, Hossein Bannazadeh Baghi, Darya Javadrashid, Souzan Najafi, Meriadeg Ar Gouilh, Behzad Baradaran
The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV. Archives of virology 166 (3) (2021)
Parvaneh Mahinfar, Behzad Baradaran, Sadaf Davoudian, Fatemeh Vahidian, William Chi Shing Cho, Behzad Mansoori
Long Non-Coding RNAs in Multidrug Resistance of Glioblastoma. Genes 12 (3) (2021)
Mahdi Abdoli Shadbad, Sahar Safaei, Oronzo Brunetti, Afshin Derakhshani, Parisa Lotfinejad, Ahad Mokhtarzadeh, Nima Hemmat, Vito Racanelli, Antonio Giovanni Solimando, Antonella Argentiero, Nicola Silvestris, Behzad Baradaran
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery. Genes 12 (8) (2021)
Shiva Najjary, Reza Mohammadzadeh, Behzad Mansoori, Fatemeh Vahidian, Ali Mohammadi, Mohammad Amin Doustvandi, Vahid Khaze, Khalil Hajiasgharzadeh, Behzad Baradaran
Combination therapy with miR-34a and doxorubicin synergistically induced apoptosis in T-cell acute lymphoblastic leukemia cell line. Medical oncology (Northwood, London, England) 38 (12) (2021)
Farnaz Rasi Bonab, Amir Baghbanzadeh, Moslem Ghaseminia, Nadia Bolandi, Ahad Mokhtarzadeh, Mohammad Amini, Kianoosh Dadashzadeh, Khalil Hajiasgharzadeh, Behzad Baradaran, Hossein Bannazadeh Baghi
Molecular pathways in the development of HPV-induced cervical cancer. EXCLI journal 20 (2021)
Afshin Derakhshani, Zeinab Rostami, Hossein Safarpour, Mahdi Abdoli Shadbad, Niloufar Sadat Nourbakhsh, Antonella Argentiero, Sina Taefehshokr, Neda Jalili Tabrizi, Omid Kooshkaki, Reza Vaezi Astamal, Pankaj Kumar Singh, Nima Taefehshokr, Nazila Alizadeh, Nicola Silvestris, Behzad Baradaran
From Oncogenic Signaling Pathways to Single-Cell Sequencing of Immune Cells: Changing the Landscape of Cancer Immunotherapy. Molecules (Basel, Switzerland) 26 (8) (2021)
Shima Khajouee, Elham Baghbani, Ali Mohammadi, Behzad Mansoori, Dariush Shanehbandi, Khalil Hajiasgharzadeh, Behzad Baradaran
Downregulation of HMGA2 by Small Interfering RNA Affects the Survival, Migration, and Apoptosis of Prostate Cancer Cell Line. Advanced pharmaceutical bulletin 12 (2) (2021)
Nayer Hosseinahli, Tahereh Zeinali, Nasrin Hosseinahli, Leila Karimi, Dariush Shanehbandi, Behzad Mansoori, Ali Mohammadi, Tohid Kazemi, Khalil Hajiasgharzadeh, Behzad Baradaran
Restoration of miRNA-143 Expression Inhibits Growth and Migration of MKN-45 Gastric Cancer Cell Line. Advanced pharmaceutical bulletin 12 (1) (2020)
Somaiyeh Malekghasemi, Jafar Majidi, Amir Baghbanzadeh, Jalal Abdolalizadeh, Behzad Baradaran, Leili Aghebati Maleki
Tumor-Associated Macrophages: Protumoral Macrophages in Inflammatory Tumor Microenvironment. Advanced pharmaceutical bulletin 10 (4) (2020)
Marjan Aghajani, Ahad Mokhtarzadeh, Leili Aghebati-Maleki, Behzad Mansoori, Ali Mohammadi, Sahar Safaei, Zahra Asadzadeh, Khalil Hajiasgharzadeh, Vahid Khaze Shahgoli, Behzad Baradaran
CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel. Molecular biology reports 47 (5) (2020)
Somaiyeh Malekghasemi, Jafar Majidi, Behzad Baradaran, Leili Aghebati Maleki
Prostate cancer cells modulate the differentiation of THP-1 cells in response to etoposide and TLR agonists treatments. Cell biology international 44 (10) (2020)
Shirin Azarbarzin, Reza Safaralizadeh, Seyed Mahdi Banan Khojasteh, Amir Baghbanzadeh, Behzad Baradaran
Current perspectives on the dysregulated microRNAs in gastric cancer. Molecular biology reports 47 (9) (2020)
Masoud Nouri-Vaskeh, Leila Alizadeh, Khalil Haji-Asgarzadeh, Ahad Mokhtarzadeh, Monireh Halimi, Behzad Baradaran
The role of HSP90 molecular chaperones in hepatocellular carcinoma. Journal of cellular physiology 235 (12) (2020)
Abolfazl Vahhabi, Alka Hasani, Mohammad Ahangarzadeh Rezaee, Behzad Baradaran, Akbar Hasani, Hossein Samadi Kafil, Faeze Abbaszadeh, Leila Dehghani
A plethora of carbapenem resistance in Acinetobacter baumannii: no end to a long insidious genetic journey. Journal of chemotherapy (Florence, Italy) 33 (3) (2020)
Arezoo Hosseini, Tohid Gharibi, Faroogh Marofi, Mahsa Javadian, Zohreh Babaloo, Behzad Baradaran
Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases. Journal of cellular physiology 235 (9) (2020)
Zeynab Aaliyari-Serej, Ayyub Ebrahimi, Balal Barazvan, Abbas Ebrahimi-Kalan, Khalil Haji-Asgarzadeh, Tohid Kazemi, Behzad Baradaran
Recent Advances in Targeting of Breast Cancer Stem Cells Based on Biological Concepts and Drug Delivery System Modification. Advanced pharmaceutical bulletin 10 (3) (2020)
Ali Mohammadi, Behzad Mansoori, Pascal H G Duijf, Elham Safarzadeh, Leila Tebbi, Souzan Najafi, Behrooz Shokouhi, Grith Lykke Sorensen, Uffe Holmskov, Behzad Baradaran
Restoration of miR-330 expression suppresses lung cancer cell viability, proliferation, and migration. Journal of cellular physiology 236 (1) (2020)
Behzad Mansoori, Ali Mohammadi, Fereydoon Abedi-Gaballu, Soheil Abbaspour-Ravasjani, Mehri Ghasabi, Reza Yekta, Solmaz Shirjang, Gholamreza Dehghan, Michael Richard Hamblin, Behzad Baradaran
Hyaluronic acid-decorated liposomal nanoparticles for targeted delivery of 5-fluorouracil into HT-29 colorectal cancer cells. Journal of cellular physiology 235 (10) (2020)
Afshin Derakhshani, Nicola Silvestris, Nima Hemmat, Zahra Asadzadeh, Mahdi Abdoli Shadbad, Niloufar Sadat Nourbakhsh, Leila Mobasheri, Parviz Vahedi, Morteza Shahmirzaie, Oronzo Brunetti, Hossein Safarpour, Behzad Baradaran
Targeting TGF-β-Mediated SMAD Signaling Pathway via Novel Recombinant Cytotoxin II: A Potent Protein from Naja naja oxiana Venom in Melanoma. Molecules (Basel, Switzerland) 25 (21) (2020)
Parisa Lotfinejad, Zahra Asadzadeh, Shiva Najjary, Mohammad Hossein Somi, Khalil Haji-Asgarzadeh, Ahad Mokhtarzadeh, Afshin Derakhshani, Elmira Roshani, Behzad Baradaran
COVID-19 Infection: Concise Review Based on the Immunological Perspective. Immunological investigations (2020)
Basira Najafzadeh, Zahra Asadzadeh, Rohollah Motafakker Azad, Ahad Mokhtarzadeh, Amir Baghbanzadeh, Hajar Alemohammad, Mahdi Abdoli Shadbad, Parisa Vasefifar, Souzan Najafi, Behzad Baradaran
The oncogenic potential of NANOG: An important cancer induction mediator. Journal of cellular physiology 236 (4) (2020)
Saeed Noorolyai, Elham Baghbani, Dariush Shanehbandi, Vahid Khaze Shahgoli, Amir Baghbanzadeh Kojabad, Behzad Mansoori, Khalil Hajiasgharzadeh, Ahad Mokhtarzadeh, Behzad Baradaran
miR-146a-5p and miR-193a-5p Synergistically Inhibited the Proliferation of Human Colorectal Cancer Cells (HT-29 cell line) through ERK Signaling Pathway. Advanced pharmaceutical bulletin 11 (4) (2020)
Omid Kooshkaki, Afshin Derakhshani, Negar Hosseinkhani, Mitra Torabi, Sahar Safaei, Oronzo Brunetti, Vito Racanelli, Nicola Silvestris, Behzad Baradaran
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials. International journal of molecular sciences 21 (12) (2020)
Elshan Bajhan, Behzad Mansoori, Ali Mohammadi, Dariush Shanehbandi, Vahid Khaze Shahgoli, Elham Baghbani, Khalil Haji-Asgarzadeh, Behzad Baradaran
MicroRNA-143 inhibits proliferation and migration of prostate cancer cells. Archives of physiology and biochemistry (2020)
Omid Kooshkaki, Afshin Derakhshani, Hossein Safarpour, Souzan Najafi, Parviz Vahedi, Oronzo Brunetti, Mitra Torabi, Parisa Lotfinejad, Angelo Virgilio Paradiso, Vito Racanelli, Nicola Silvestris, Behzad Baradaran
The Latest Findings of PD-1/PD-L1 Inhibitor Application in Gynecologic Cancers. International journal of molecular sciences 21 (14) (2020)
Amir Baghbanzadeh, Elham Baghbani, Khalil Hajiasgharzadeh, Saeed Noorolyai, Vahid Khaze, Behzad Mansoori, Masoud Shirmohamadi, Behzad Baradaran, Ahad Mokhtarzadeh
microRNA-193a-5p Suppresses the Migratory Ability of Human KATO III Gastric Cancer Cells through Inhibition of Vimentin and MMP-9. Advanced pharmaceutical bulletin 12 (1) (2020)
Sanaz Naghizadeh, Ali Mohammadi, Pascal H G Duijf, Behzad Baradaran, Elham Safarzadeh, William Chi Shing Cho, Behzad Mansoori
The role of miR-34 in cancer drug resistance. Journal of cellular physiology 235 (10) (2020)
Parisa Lotfinejad, Mohammad Asghari Jafarabadi, Mahdi Abdoli Shadbad, Tohid Kazemi, Fariba Pashazadeh, Siamak Sandoghchian Shotorbani, Farhad Jadidi Niaragh, Amir Baghbanzadeh, Nafiseh Vahed, Nicola Silvestris, Behzad Baradaran
Prognostic Role and Clinical Significance of Tumor-Infiltrating Lymphocyte (TIL) and Programmed Death Ligand 1 (PD-L1) Expression in Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis Study. Diagnostics (Basel, Switzerland) 10 (9) (2020)
Nafiseh Paydarnia, Behzad Mansoori, Davoud Esmaeili, Tohid Kazemi, Mahyar Aghapour, Khalil Hajiasgharzadeh, Nazila Alizadeh, Behzad Baradaran
Helicobacter pylori Recombinant CagA Regulates Th1/Th2 Balance in a BALB/c Murine Model. Advanced pharmaceutical bulletin 10 (2) (2020)
Asiyeh Jebelli, Behzad Baradaran, Jafar Mosafer, Amir Baghbanzadeh, Ahad Mokhtarzadeh, Lobat Tayebi
Recent developments in targeting genes and pathways by RNAi-based approaches in colorectal cancer. Medicinal research reviews 41 (1) (2020)
Alireza Isazadeh, Saba Hajazimian, Hamid Garshasbi, Behrouz Shadman, Amir Baghbanzadeh, Reza Chavoshi, Sina Taefehshokr, Mahdieh Farhoudi Sefidan Jadid, Khalil Hajiasgharzadeh, Behzad Baradaran
Resistance mechanisms to immune checkpoints blockade by monoclonal antibody drugs in cancer immunotherapy: Focus on myeloma. Journal of cellular physiology 236 (2) (2020)
Narges Dastmalchi, Behzad Baradaran, Seyed Mahdi Banan Khojasteh, Mohammadali Hosseinpourfeizi, Reza Safaralizadeh
miR-424: A novel potential therapeutic target and prognostic factor in malignancies. Cell biology international 45 (4) (2020)
Sina Abdkarimi, Saiedeh Razi Soofiyani, Goli Elham, Hossein Mashhadi Abdolahi, Elham Safarzadeh, Behzad Baradaran
Targeting immune checkpoints: Building better therapeutic puzzle in pancreatic cancer combination therapy. European journal of cancer care 29 (5) (2020)
Elnaz Faghfuri, Farhad Pourfarzi, Amir Hossein Faghfouri, Mahdi Abdoli Shadbad, Khalil Haji-Asgarzadeh, Behzad Baradaran
Recent developments of RNA-based vaccines in cancer immunotherapy. Expert opinion on biological therapy 21 (2) (2020)
Negar Hosseinkhani, Afshin Derakhshani, Omid Kooshkaki, Mahdi Abdoli Shadbad, Khalil Haji-Asgarzadeh, Amir Baghbanzadeh, Hossein Safarpour, Ahad Mokhtarzadeh, Oronzo Brunetti, Simon C Yue, Nicola Silvestris, Behzad Baradaran
Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies? International journal of molecular sciences 21 (21) (2020)
Omid Kooshkaki, Zohre Rezaei, Meysam Rahmati, Parviz Vahedi, Afshin Derakhshani, Oronzo Brunetti, Amir Baghbanzadeh, Behzad Mansoori, Nicola Silvestris, Behzad Baradaran
MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers. International journal of molecular sciences 21 (7) (2020)
Zahra Asadzadeh, Elham Safarzadeh, Sahar Safaei, Ali Baradaran, Ali Mohammadi, Khalil Haji-Asgarzadeh, Afshin Derakhshani, Antonella Argentiero, Nicola Silvestris, Behzad Baradaran
Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death. Cancers 12 (4) (2020)
Zahra Payandeh, Saeed Khalili, Mohammad Hossein Somi, Maysam Mard-Soltani, Amir Baghbanzadeh, Khalil Haji-Asgarzadeh, Nasser Samadi, Behzad Baradaran
PD-1/PD-L1-dependent immune response in colorectal cancer. Journal of cellular physiology 235 (7-8) (2020)
Solmaz Shirjang, Behzad Mansoori, Ali Mohammadi, Neda Shajari, Pascal H G Duijf, Souzan Najafi, Fereydoon Abedi Gaballu, Katayoon Nofouzi, Behzad Baradaran
miR-330 Regulates Colorectal Cancer Oncogenesis by Targeting BACH1. Advanced pharmaceutical bulletin 10 (3) (2020)
Saeed Noorolyai, Elham Baghbani, Leili Aghebati Maleki, Amir Baghbanzadeh Kojabad, Dariush Shanehbansdi, Vahid Khaze Shahgoli, Ahad Mokhtarzadeh, Behzad Baradaran
Restoration of miR-193a-5p and miR-146 a-5p Expression Induces G1 Arrest in Colorectal Cancer through Targeting of MDM2/p53. Advanced pharmaceutical bulletin 10 (1) (2019)
Elnaz Mosaferi, Nazila Alizadeh, Laya Farzadi, Jafar Majidi, Zohreh Babaloo, Tohid Kazemi, Mehrnoosh Ramezani, Meraj Tabatabaei, Hamid Ahmadi, Leili Aghebati Maleki, Behzad Baradaran
The Study of HLA-G Gene and Protein Expression in Patients with Recurrent Miscarriage. Advanced pharmaceutical bulletin 9 (1) (2019)
Mahsa Javadian, Najibeh Shekari, Mohammad Sadegh Soltani-Zangbar, Ali Mohammadi, Behzad Mansoori, Sepideh Maralbashi, Dariush Shanehbandi, Behzad Baradaran, Masood Darabi, Tohid Kazemi
Docosahexaenoic acid suppresses migration of triple-negative breast cancer cell through targeting metastasis-related genes and microRNA under normoxic and hypoxic conditions. Journal of cellular biochemistry 121 (3) (2019)
Navid Shomali, Behzad Baradaran, Mina Deljavanghodrati, Morteza Akbari, Maryam Hemmatzadeh, Hamed Mohammadi, Yue Jang, Huaxi Xu, Siamak Sandoghchian Shotorbani
A new insight into thymosin β4, a promising therapeutic approach for neurodegenerative disorders. Journal of cellular physiology 235 (4) (2019)
Nasser Sehati, Navaz Sadeghie, Behzad Mansoori, Ali Mohammadi, Dariush Shanehbandi, Behzad Baradaran
MicroRNA-330 inhibits growth and migration of melanoma A375 cells: In vitro study. Journal of cellular biochemistry 121 (1) (2019)
Afshin Derakhshani, Zohreh Rezaei, Hossein Safarpour, Morteza Sabri, Atefeh Mir, Mohammad Amin Sanati, Fatemeh Vahidian, Ali Gholamiyan Moghadam, Ali Aghadoukht, Khalil Hajiasgharzadeh, Behzad Baradaran
Overcoming trastuzumab resistance in HER2-positive breast cancer using combination therapy. Journal of cellular physiology 235 (4) (2019)
Behzad Mansoori, Ali Mohammadi, Morten Frier Gjerstorff, Solmaz Shirjang, Zahra Asadzadeh, Vahid Khaze Shahgoli, Uffe Holmskov, Tohid Kazemi, Pascal H G Duijf, Behzad Baradaran
miR-142-3p is a tumor suppressor that inhibits estrogen receptor expression in ER-positive breast cancer. Journal of cellular physiology (2019)
Jalil Rashedi, Amir Ghorbani Haghjo, Mehran Mesgari Abbasi, Ali Dastranj Tabrizi, Shadi Yaqoubi, Davoud Sanajou, Zahra Ashrafi Jigheh, Ali Namvaran, Ali Mohammadi, Jalal Mohammadi Khoshraj, Behzad Baradaran
Anti-tumor Effect of Quercetin Loaded Chitosan Nanoparticles on Induced Colon Cancer in Wistar Rats. Advanced pharmaceutical bulletin 9 (3) (2019)
Mohsen Alizadeh, Ali Safarzadeh, Fatemeh Beyranvand, Fatemeh Ahmadpour, Khalil Hajiasgharzadeh, Amir Baghbanzadeh, Behzad Baradaran
The potential role of miR-29 in health and cancer diagnosis, prognosis, and therapy. Journal of cellular physiology 234 (11) (2019)
Vahid Asghariazar, Ebrahim Sakhinia, Behzad Mansoori, Ali Mohammadi, Behzad Baradaran
Tumor suppressor microRNAs in lung cancer: An insight to signaling pathways and drug resistance. Journal of cellular biochemistry 120 (12) (2019)
Khalil Haji-Asgarzadeh, Saeed Sadigh-Eteghad, Behzad Mansoori, Ahad Mokhtarzadeh, Dariush Shanehbandi, Mohammad Amin Doustvandi, Zahra Asadzadeh, Behzad Baradaran
Alpha7 nicotinic acetylcholine receptors in lung inflammation and carcinogenesis: Friends or foes? Journal of cellular physiology (2019)
Behzad Mansoori, Ali Mohammadi, Dariush Shanehbandi, Morten Gjerstorff, Dariush Shanehbandi, Solmaz Shirjang, Souzan Najafi, Uffe Holmskov, Vahid Khaze, Pascal H G Duijf, Behzad Baradaran
miR-330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancer. Journal of cellular physiology 235 (2) (2019)
Sama Izadpanah, Parastoo Shabani, Ali Aghebati-Maleki, Amir Baghbanzadeh, Ali Fotouhi, Amir Bisadi, Leili Aghebati Maleki, Behzad Baradaran
Prospects for the involvement of cancer stem cells in the pathogenesis of osteosarcoma. Journal of cellular physiology 235 (5) (2019)
Mehri Ghasabi, Jafar Majidi, Behzad Mansoori, Ali Mohammadi, Navid Shomali, Naghmeh Shirafkan, Elham Baghbani, Tohid Kazemi, Behzad Baradaran
The effect of combined miR-200c replacement and cisplatin on apoptosis induction and inhibition of gastric cancer cell line migration. Journal of cellular physiology 234 (12) (2019)
Behzad Mansoori, Ali Mohammadi, Zahra Asadzadeh, Solmaz Shirjang, Mahsa Minouei, Fereydoon Abedi-Gaballu, Neda Shajari, Tohid Kazemi, Morten Frier Gjerstorff, Pascal H G Duijf, Behzad Baradaran
HMGA2 and Bach-1 cooperate to promote breast cancer cell malignancy. Journal of cellular physiology 234 (10) (2019)
Habib Zarredar, Shadi Pashapour, Safar Farajniya, Khalil Ansarin, Behzad Baradaran, Vahideh Ahmadzadeh, Fatemeh Safari
Targeting the KRAS, p38α, and NF-κB in lung adenocarcinoma cancer cells: The effect of combining RNA interferences with a chemical inhibitor. Journal of cellular biochemistry 120 (6) (2019)
Masoumeh Fardi, Mohammad Reza Alivand, Behzad Baradaran, Majid Farshdousti Hagh, Saeed Solali
The crucial role of ZEB2: From development to epithelial-to-mesenchymal transition and cancer complexity. Journal of cellular physiology (2019)
Marjan Aghajani, Behzad Mansoori, Ali Mohammadi, Zahra Asadzadeh, Behzad Baradaran
New emerging roles of CD133 in cancer stem cell: Signaling pathway and miRNA regulation. Journal of cellular physiology 234 (12) (2019)

Behzad Baradaran.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Behzad Baradaran